Related Experiment Videos
massive peripapillary subretinal neovascularization: an indication for submacular surgery
1University of Ottawa Eye Institute, The Ottawa Hospital, Ottawa, Ontario, Canada. peter.kertes@sw.ca
Retina (Philadelphia, Pa.)
|April 21, 2004
Summary
Submacular surgery improved vision in patients with ocular histoplasmosis syndrome. This treatment for subretinal neovascularization was safe and beneficial in a small patient series.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Surgical Innovation
Background:
- Ocular histoplasmosis syndrome can cause subretinal neovascularization.
- Massive peripapillary subretinal neovascularization poses a significant threat to vision.
- Limited treatment options exist for this condition.
Purpose of the Study:
- To evaluate the safety and efficacy of submacular surgery.
- To describe the clinical course and outcomes.
- To assess visual acuity and complications in patients with ocular histoplasmosis syndrome.
Main Methods:
- Submacular surgery was performed on three patients.
- Patients were followed for an average of 41 months.
- Outcomes measured included visual acuity, complications, and recurrence.
Main Results:
- Significant visual acuity improvement was observed in all three patients.
- One patient experienced a treatable retinal tear postoperatively.
- No cases of visually significant cataract, retinal detachment, or recurrence were noted.
Conclusions:
- Submacular surgery is a safe and effective option.
- It offers visual benefits for massive peripapillary subretinal neovascularization.
- Consideration for this uncommon presentation is warranted.